India Pharmaceutical Logistics Market Forecast 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,100	146 Pages	Inkwood Research	May, 2024	INKR18766849

Best Price Guarantee
Price	from $1,100
Length	146 Pages
Publisher	Inkwood Research
Published Date	May, 2024
SKU	INKR18766849

India Pharmaceutical Logistics Market Forecast 2024-2032

KEY FINDINGS

The India pharmaceutical logistics market is predicted to develop at a CAGR of 9.00% during the forecast period 2024-2032. Diverse enablers foster market growth, like the rising need for temperature-controlled solutions in pharmaceuticals, the expansion of ocean freight services in the pharmaceutical industry, the rise in consumer preference for over-the-counter medicines, and the surge in pharmaceutical logistics during the India COVID-19 pandemic.

MARKET INSIGHTS

The India pharmaceutical logistics market is a strong evolving sector that plays a vital role in ensuring the timely and efficient distribution of pharmaceutical products across the country. With India's pharmaceutical industry experiencing robust growth and diversification, driven by factors such as increasing healthcare spending, a growing population, and rising demand for quality healthcare products, the need for reliable and effective logistics solutions has become paramount.

Pharmaceutical logistics in India includes a range of services including transportation, warehousing, inventory management, cold chain logistics for temperature-sensitive products, and regulatory compliance. The market is characterized by a network of logistics providers, including third-party logistics (3PL) companies, pharmaceutical distributors, freight forwarders, and specialized cold-chain logistics providers, all working together to meet the unique requirements of the pharmaceutical supply chain.

The implementation of Good Distribution Practices (GDP) and stringent regulatory standards have further pushed the demand for advanced pharmaceutical logistics solutions in India. Market players are investing in technology-driven solutions such as track-and-trace systems, temperature monitoring devices, and digital platforms to ensure product integrity, regulatory compliance, and supply chain visibility. As India's pharmaceutical domain continues to expand and innovate, the pharmaceutical logistics market is poised for sustained growth, driven by the increasing complexity and sophistication of supply chain operations in the healthcare sector.

COMPETITIVE INSIGHTS

Some of the major companies in the India pharmaceutical logistics market include Agility Logistics, Cardinal Health, Cencora (AmerisourceBergen), CEVA Logistics, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors such as market share.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

1. Research Scope & Methodology: 1.1. Study Objectives; 1.2. Methodology; 1.3. Assumptions & Limitations
2. Executive Summary: 2.1. Market Size & Estimates; 2.2. Country Snapshot; 2.3. Country Analysis; 2.4. Scope Of Study; 2.5. Crisis Scenario Analysis; 2.6. Major Market Findings; 2.6.1. Branded Drugs Are The Most Commonly Used Products In The Pharmaceutical Logistics Market; 2.6.2. Communicable Diseases Hold The Largest Market Share In The Therapy Area; 2.6.3. Cold Chain Logistics Is The Fastest-growing Type Within The Pharmaceutical Logistics Market; 2.6.4. Monitoring Of Pharmaceutical Logistics Operations Is Increasingly Becoming A Focus Area
3. Market Dynamics: 3.1. Key Drivers; 3.1.1. Rising Need For Temperature-controlled Solutions In Pharmaceuticals; 3.1.2. Expansion Of Ocean Freight Services In Pharmaceutical Industry; 3.1.3. Rise In Consumer Preference For Over-the-counter Medicines; 3.1.4. Surge In Pharmaceutical Logistics During The India Covid-19 Pandemic; 3.2. Key Restraints; 3.2.1. Rigorous Regulatory Requirements In Pharmaceutical Logistics; 3.2.2. Ensuring Real-time Transparency And Reliability In Pharmaceutical Logistics
4. Key Analytics: 4.1. Key Market Trends; 4.1.1. Surge In Demand For Cell & Gene Therapy Logistics; 4.1.2. Revolutionizing Pharmaceutical Logistics Through Digital Transformation; 4.1.3. Increasing Clinical Trials Logistics Demands; 4.2. Porter’s Five Forces Analysis; 4.2.1. Buyers Power; 4.2.2. Suppliers Power; 4.2.3. Substitution; 4.2.4. New Entrants; 4.2.5. Industry Rivalry; 4.3. Growth Prospect Mapping; 4.3.1. Growth Prospect Mapping For India; 4.4. Market Concentration Analysis; 4.5. Value Chain Analysis; 4.5.1. Manufacturing; 4.5.2. Storage; 4.5.3. Transportation; 4.5.4. Distribution; 4.5.5. Monitoring Components; 4.5.6. Consumption; 4.6. Key Buying Criteria; 4.6.1. Type Of Logistics; 4.6.2. Services Offered; 4.6.3. Mode Of Transportation; 4.6.4. Application; 4.6.5. Regulatory Compliance; 4.6.6. Technological Capabilities; 4.6.7. Cost; 4.6.8. Reliability; 4.6.9. Agility
5. Market By Product: 5.1. Branded Drugs; 5.1.1. Market Forecast Figure; 5.1.2. Segment Analysis; 5.2. Generic Drugs; 5.2.1. Market Forecast Figure; 5.2.2. Segment Analysis; 5.3. Otc; 5.3.1. Market Forecast Figure; 5.3.2. Segment Analysis
6. Market By Therapy Area: 6.1. Communicable Diseases; 6.1.1. Market Forecast Figure; 6.1.2. Segment Analysis; 6.2. Oncology; 6.2.1. Market Forecast Figure; 6.2.2. Segment Analysis; 6.3. Diabetes; 6.3.1. Market Forecast Figure; 6.3.2. Segment Analysis; 6.4. Cardiovascular Diseases; 6.4.1. Market Forecast Figure; 6.4.2. Segment Analysis; 6.5. Autoimmune Diseases; 6.5.1. Market Forecast Figure; 6.5.2. Segment Analysis; 6.6. Neurological Disorders; 6.6.1. Market Forecast Figure; 6.6.2. Segment Analysis; 6.7. Pain Management; 6.7.1. Market Forecast Figure; 6.7.2. Segment Analysis; 6.8. Respiratory Diseases; 6.8.1. Market Forecast Figure; 6.8.2. Segment Analysis; 6.9. Other Therapy Areas; 6.9.1. Market Forecast Figure; 6.9.2. Segment Analysis
7. Market By Type: 7.1. Non-cold Chain Logistics; 7.1.1. Market Forecast Figure; 7.1.2. Segment Analysis; 7.2. Cold Chain Logistics; 7.2.1. Market Forecast Figure; 7.2.2. Segment Analysis
8. Market By Component: 8.1. Storage; 8.1.1. Warehouse; 8.1.1.1. Market Forecast Figure; 8.1.1.2. Segment Analysis; 8.1.2. Refrigerated Containers; 8.1.2.1. Market Forecast Figure; 8.1.2.2. Segment Analysis; 8.2. Transportation; 8.2.1. Overland Logistics; 8.2.1.1. Market Forecast Figure; 8.2.1.2. Segment Analysis; 8.2.2. Sea Freight Logistics; 8.2.2.1. Market Forecast Figure; 8.2.2.2. Segment Analysis; 8.2.3. Air Freight Logistics; 8.2.3.1. Market Forecast Figure; 8.2.3.2. Segment Analysis; 8.3. Monitoring Components; 8.3.1. Hardware; 8.3.1.1. Sensors; 8.3.1.1.1. Market Forecast Figure; 8.3.1.1.2. Segment Analysis; 8.3.1.2. Rfid Devices; 8.3.1.2.1. Market Forecast Figure; 8.3.1.2.2. Segment Analysis; 8.3.1.3. Telematics; 8.3.1.3.1. Market Forecast Figure; 8.3.1.3.2. Segment Analysis; 8.3.1.4. Networking Devices; 8.3.1.4.1. Market Forecast Figure; 8.3.1.4.2. Segment Analysis; 8.3.2. Software; 8.3.2.1. Market Forecast Figure; 8.3.2.2. Segment Analysis
9. Competitive Landscape: 9.1. Key Strategic Developments; 9.1.1. Mergers & Acquisitions; 9.1.2. Product Launches & Developments; 9.1.3. Partnerships & Agreements; 9.1.4. Business Expansions & Divestitures; 9.2. Company Profiles; 9.2.1. Agility Logistics; 9.2.1.1. Company Overview; 9.2.1.2. Product Portfolio; 9.2.1.3. Strengths & Challenges; 9.2.2. Ap Moller - Maersk; 9.2.2.1. Company Overview; 9.2.2.2. Product Portfolio; 9.2.2.3. Strengths & Challenges; 9.2.3. Cardinal Health; 9.2.3.1. Company Overview; 9.2.3.2. Product Portfolio; 9.2.3.3. Strengths & Challenges; 9.2.4. Cencora (Amerisourcebergen); 9.2.4.1. Company Overview; 9.2.4.2. Product Portfolio; 9.2.4.3. Strengths & Challenges; 9.2.5. Ceva Logistics; 9.2.5.1. Company Overview; 9.2.5.2. Product Portfolio; 9.2.5.3. Strengths & Challenges; 9.2.6. Db Schenker; 9.2.6.1. Company Overview; 9.2.6.2. Product Portfolio; 9.2.6.3. Strengths & Challenges; 9.2.7. Deutsche Post Ag; 9.2.7.1. Company Overview; 9.2.7.2. Product Portfolio; 9.2.7.3. Strengths & Challenges; 9.2.8. Dsv; 9.2.8.1. Company Overview; 9.2.8.2. Product Portfolio; 9.2.8.3. Strengths & Challenges; 9.2.9. Fedex; 9.2.9.1. Company Overview; 9.2.9.2. Product Portfolio; 9.2.9.3. Strengths & Challenges; 9.2.10. Kuehne + Nagel; 9.2.10.1. Company Overview; 9.2.10.2. Product Portfolio; 9.2.10.3. Strengths & Challenges